Definitive Therapies for Immunodeficiency
At the end of this session, learners will be able to understand definitive therapies for immunodeficiency and the workflow for utilization of definitive therapies with…
At the end of this session, learners will be able to understand definitive therapies for immunodeficiency and the workflow for utilization of definitive therapies with…
At the end of this session, learners will be able to discuss the medical management of pediatric patients with immunodeficiency through utilization of immunoglobulin replacement,…
At the end of this session, learners will be able to understand the history of genetic testing, recall commonly used forms of genetic testing for…
At the end of this session, learners will be able to describe an overall approach to evaluation for primary immunodeficiency, including the utilization of functional…
At the end of this session, learners will be able to understand primary immune dysregulatory disorders (PIRD) associated with immune deficiency, management of autoimmunity associated…
At the end of this session, learners will be able to understand the definition of combined immunodeficiency (CID), common presenting features of CID, supportive management…
At the end of this session, learners will be able to understand an overall approach to evaluation for humoral immunodeficiency and an overview of B…
At the end of this session, learners will be able to understand an overall approach to evaluation for primary immunodeficiency (PID), how to evaluate innate…
**By selecting “Yes”, you consent to receive information from CHOP. Once you have decided to receive such communications, you may later decide to stop receiving these communications. If you want to stop receiving these communications, you may send an email message to chopopensupport@chop.edu.